Cell Wall Synthesis Inhibitors and Protein Synthesis Inhibitors Flashcards
describe the tiers of beta lactam antibiotics
penicillin and aminopenicillins: first line/tier 1
cephalosporins
1st and 2nd gen: first line/tier 1
3rd gen: tier 2
4th and 5th gen: restricted
carbapenems: restricted
give the mechanism of action of ALL beta lactams
inhibit cell wall synthesis by binding to penicillin-binding proteins (transpeptidases), preventing formation of NAG-NAM cross linkages, causing the THICK cell wall netting to become progressively porous, allowing fluid to diffuse across cell membrane and cell to swell and explode
-this class is most effective against actively dividing bacteria!
describe the prototypes/others of beta lactam penicillins
- PENICILLIN G: benzylpenicillin
-formulations:
–potassium-PenG
–sodium PenG
–Procrain PenG: absorption slower than elimination - aminopenicillins: amoxicillin, ampicillin
- extended spectrum penicillins (anti-pseudomonal)
describe the spectrum of activity of beta lactam penicillins
- time dependent! (T>MIC)
- narrow: gram + and anaerobes
- bactericidal
describe route of administration of beta lactam penicillins
- IV, IM, SQ: need to give every 6 hours (IV very common)
- IM: PROCAINE PenG: slower absorption so less frequent admin
-NEVER give IV in horses! can cause a hyperexcitable reaction that can result in trauma or death, always aspirate! - oral: amoxicillin
- intrasynovial: potassium or sodium PenG
describe disposition of beta lactam penicillins
- polar
- water soluble
- excreted unchanged in urine with some active renal tubular secretion; so if significant renal tubular secretion, be careful with dose and timing!
describe toxicity of beta lactam penicillins
- GI upset: more common in LA
- anaphylactic/allergic
- hypersensitivity reactions (IMHA, IMTP)
- PROCAINE reaction!!!
describe specific indications and contraindications of beta lactam penicillins
indication:
1. gram + infections and ANAEROBES
2. streptococcal infections
3. select atypical bacteria: leptospira, borrelia, listeria
contraindications:
1. animals with known hypersensitivity
2. NEVER give PROCAINE PenG IV
3. watch for development of staph resistance
what is the main mode of resistance to beta lactam penicillins? how do we fight this?
bacterial production of beta lactamase enzymes to chop up beta lactam ring to prevent beta lactam from binding to PBPs
we counteract with beta-lactamase inhibitors! potentiating agents that extend the spectrum of activity
-clavamox is the only veterinary labeled potentiated beta lactam drug
describe the prototype and others of beta lactam cephalosporins
1st gen: pha or fa
3rd gen: all the rest
4th gen: 2 to recall
1st gen: cephalexin, cefazolin
3rd gen: cefpodoxomine, ceftiofur, cefovecin
4th gen: cefepime, cefquinome
there is a 5th gen
describe the spectrum of activity of beta lactam cephalosporins
- bacteridical; time above the MIC for the pathogen
1st gen: (like PenG) gram + and anaerobes
3rd gen: gram +, gram -, and some anaerobes
4th gen: gran - and gram +
describe the routes of administration of beta lactam cephalosporins
ORAL: cephalexin (1st gen), cefpodoxime (3rd gen), proxetil, cefepime and cefquinome (4th gen)
PARENTERAL (SQ, IV, IM): cefazolin (1st gen), ceftiofur cefovecin and cefotaxime (3rd gen)
describe the disposition of beta lactam cephalosporins
- 1st gen similar to PenG
- as increase in generations, becomes more lipophilic (but most are still polar in this class)
- excreted unchanged in urine with some active renal tubular excretion (like penicillins)
NOTE: ceftiofur is metabolized in the plasma to the active metabolite defuroylceftiofur)
describe the toxicity of beta lactam cephalosporins
- anaphylactic
- hypersensitivity reactions (IMHA, IMTP)
- GI upset in horses
describe the specific indications and contraindications of beta lactam cephalosporins
indications:
1. skin infections
2. urinary tract infections
3. respiratory infections
contraindications:
1. animals with known hypersensitivity
give one known and clinically relevant fact about cefovecin, a 3rd gen beta lactam cephalosporin
increases free concentrations of carprofen, furosemide, doxycycline, and ketoconazole due to competitive protein binding
describe the elimination of beta lactam cephalosporins and what this means about extra-label use
LONG elimination: half life is 5.5 days so it takes 65 days to eliminate 97% of the drug
extra-label use for off-label indications in cattle, swine, and poultry is OKAY as long as all other labeled directions (dose, route, duration, frequency, species) are follow but
NO EL USE for prevention and NO ELA USE of human cephalosporins
describe beta lactam carbapenems
BIG GUNS only use with specific indications and when backed up by culture and sensitivity!!!
describe the prototype and others of beta lactam carbapenems
- imipenem
- meropenem
- dorapenem
- ertapenem
- potentiated carbapenem (imipenem with beta lactamase inhibitor cilastatin)
if reaching for these you MUST HAVE A REASON
describe the spectrum of activity of beta lactam carbapenems
- broad
- bactericidal
- time dependent
describe route of administration of beta lactam carbapenems
IV, IM, intrasynovial
POOR oral bioavailability
describe the disposition of beta lactam carbapenems
metabolized to inactive form in renal tubules (these drugs have low efficacy against UTIs)
describe the toxicity of beta lactam carbapenems
- imipenem: CNS toxicity in dogs and cats
- GI upset
- anaphylactic
- hypersensitivity reactions (IMHA and IMTP)
describe specific indications and contraindications of beta lactam carbapenems
indications: treatment of infection resistant to first and second tier beta lactams IF you think it will help for real
contraindications: due to CNS toxicity of imipenem
1. meningitis
2. head trauma or seizure disorder
describe antimicrobial stewardship as it related to beta lactam carbapenems
this class is typically reserved for treatment of HUMANS with resistant infection or severe systemic illness due to the emergence of carbapenemase producing enterobactericeae
describe the tiers of aminoglycoside antibiotics
first line/tier 1 EQUINE
tier 2 in small animals!!
RESTRICTED in food producing animals
describe the mechanism of action of aminoglycoside antibiotics
inhibit protein synthesis via 30S ribosomal subunit but OXYGEN DEPENDENT (NO anaerobic action!!)
describe the prototype and others of aminoglycosides
systemic activity, IV, IM, SQ: amikacin, gentamicin
not systemic and topical only: neomycin, kanamycin, tobramycin, streptomycin
describe the spectrum of activity of aminoglycosides
CONCENTRATION DEPENDENT; uniquely bactericidal!!!
narrow spectrum: GRAM - AEROBES!!
(some SELECT gram + cocci, mycoplasma)
describe route of administration of aminoglycosides
IV, IM, SQ, intrasynovial or topically (ophthalmic/otic)
NO oral bioavailability: must catheterize or stick muscle! can’t send these home!
describe the disposition of aminoglycosides
- highly polar: no good cell penetrating availability, use water channels to penetrate bacteria
- inactivated in purulent material
- renal excretion: accumulation in proximal renal tubular epithelial cells
describe the toxicity of aminoglycosides (NON
- nephrotoxicity
- ototoxicity
- neurotoxicity
therapeutic drug monitoring is key!
describe specific indications and contraindications of aminoglycosides
indications:
1. susceptible gram - infections: enterobacteriaceae
2. polymicrobial coverage: combination therapy with beta lactam
3. achieve high concentrations in the URINE
contraindications:
1. dehydration/hypovolemia
2. renal injury/insufficiency
3. during general anesthesia
4. voluntary ban in food producing animals: 18 months meat withdrawal
describe synergism of beta lactam and aminoglycoside antibiotics
for polymicrobial infections and critically ill sepsis (take care with kidneys!)
synergy: disruption of gram + cell wall enhances aminoglycoside penetration into the cell
describe tiers of tetracycline antibiotics
tetracyclines: first line/tier 1 in small animals and food producing animals
doxycycline/minocycline: tier 2 in small animal dermatitis and equine
describe the mechanism of action of tetracyclines
inhibit protein synthesis of protein synthesis via 30s ribosomal subunit but does not require oxygen like aminoglycosides!!
describe the prototype and others of tetracyclines
feed additives: tetracycline, oxytetracycline, chlortetracycline
companion and equine: doxycycline, minocycline
describe the spectrum of activity of tetracyclines
- TIME DEPENDENT (maybe some AUC:MIC)
- bacterioSTATIC
- broad spectrum! Gram - and +, some anaerobes (beware resistance) AND
-atypical bacteria:
rickettsia, mycoplasma, leptospira, chlamydophila
describe route of administration of tetracyclines
IV, SQ: oxytetracycline
Oral: doxycycline and minocycline
-bioavailability is 50-60% in dogs but lower in farm and equine
ophthalimic, topical
describe the disposition of tetracyclines
- moderately lipophilic
- amphoteric- always ionized = active
- chelates: cations
4 high protein binding (esp doxycycline) - MIXED:
-renal excretion: active drug in urine (oxytet) and
-liver: enterohepatic circulation, hepatic metabolism (doxycycline, minocycline)
describe the toxicity of tetracyclines
- nephrotoxicity
- GI:
-esophageal structure due to oral doxycycline
-GI upset
-enamel hypoplasia (discolored teeth) - FATAL:
-IV doxycycline in horses
-collapse with rapid admin of IV oxytetracycline
give specific indications and contraindication of tetracyclines
specific indications:
1. for fairly broad spectrum coverage
2. atypical or INTRACELLULAR bacterial infections
-mycoplasma, ricketsia, ehrlichia, anaplasma, leptospira, borrelia
3. TICK BORNE DISEASE: treatment of choice
4. potomac horse fever (neorickettsia risticii)
5. wolbachia in dogs with heartworm infections
contraindications:
1. hypovolemia/dehydration
2. renal injury/insufficiency
describe the tiers of macrolide, lincosamides, and fenicol antibiotics as well as mechanism of action
lincosamides: first line/tier 1 for all
florfenicol: tier 1 for food animal
macrolides and fenicols: tier 2
all are protein synthesis inhibitors via the 50S ribosome subunit; macrolides and lincosamides bind at the same site, but chlorampehnicols bind at a different site
describe the prototype and others of macrolides
for foals and small animals: erythromycin, clarithromycin, tylosin, azithromycin
for ruminants and pigs: tulathromycin, tildipirosin, gamithromycin, tilcomisin
describe the spectrum of activity of macrolides
- time DEPENDENT
- bacterioSTATIC
- narrow spectrum: gram + AErobes and select anaerobes
-SOME gram - pathogens: BRD/SRD - unique: effective against mycoplasma
describe route of administration of macrolides
oral OR SQ, IM, IV
describe disposition of macrolide antibiotics
- highly lipophilic
- high concentration in leukocytes
- significant post-antibiotic effect
describe toxicity of macrolides
- FATAL COLITIS in hindgut fermentors (adult horses, bunny, guinea pig)
- tilcomisin: cardiotoxicity in people and goats
- erythromycin: hyperthermia in foals due to partial anhidrosis/inabiltiy to sweat appropriately (reversible)
describe specific indications and contraindications of macrolides
specific indications:
1. rhodococcus equi (with rifampin)
2. bovine respiratory disease complex (BRDC; including mycoplasma)
3. swine respiratory disease complex (SRD)
contraindications:
oral admin to hindgut fermentors
what are 2 other effects of macrolides?
- anti-inflammatory
-reduce airway mucous secondary to effects on interleukin and neutrophil influx
-tylosin: companion animal treatment for anti-inflam bowel disease - prokinetic:
-erythromycin effect on motilin Rc in horses with ileus and ruminants with abomasal atony to increase motility but have to give IV and just a small amount so for antimicrobial stewardship purposes we don’t do that anymore
describe the prototype and others for lincosamides
for cats: clindamycin
for swine: lincomycin
intramammary for ruminants with mastitis: pirlimycin
describe the spectrum of activity for lincosamides
- time DEPENDENT
- bacterioSTATIC
- narrow spectrum: gram + aerobes and anaerobes similar to macrolides
-NO GRAM - COVERAGE!!: intrinsic resistance of pasteurellaceae and enterobacteraceae
describe routes of administration for lincosamides
clindamycin: oral suspension causes profuse salivation in cats
these are mostly oral with the exception of pirlimycin (intramammary)
describe disposition of lincosamides
highly lipophilic
describe toxicity of lincosamides
- FATAL COLITIS in hindgut fermentors (macrolides too)
- diarrhea in nursing puppies and kittens
describe specific indications and contraindications of lincosamides
specific indications:
1. staphylococcal infections
2. oral abscess: dogs and cats
3. osteomyelitis/dental disease
contraindications:
1. oral admin to hindgut fermentors; DONT
2. oral admin to cattle
describe prototype and others of chloramphenicol antibiotics
chloramphenicol and florfenicol
describe the spectrum of activity of chloramphenicols
- time DEPENDENT
- chloramphenicol: bacterioSTATIC
- florfenicol: bacteriCIDAL against select pathogens
- BROAD activity: gram +, -, and anaerobes
describe route of administration of chloramphenicols
oral, SQ, IM
describe disposition of chloramphenicols
- highly lipophilic
- BBB and BPB cross
- hepatic metabolism/some renal clearance
describe toxicity of chloramphenicols
chloramphenicol:
-people: fatal aplastic anemia
-dose dependent bone marrow suppression
florfenicol:
-GI upset
-injection site pain: RESTRAIN bc it STINGS
-colitis in horses
describe specific indications and contraindications of chloramphenicols
specific indications:
1. chronic therapy for abscess, osteomyelitis
2. florfenicol: foot rot, BRD, SRD
contraindications:
1. hepatic/renal disease
2. dogs on phenobarbital: will increase phenobarb levels
3. CHLORAMPHENICOL BANNED IN FOOD ANIMALS because fatal aplastic anemia in people
4. don’t give florfenicol to horses: colitis